SCHEMBL27014131

SCHEMBL27014131

O=C(O)[C@@H]1C[C@@H](O)c2ccccc2O1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.39
HPGD P15428 2/20 0.38
EDNRA P25101 1/20 0.38
TSHR P16473 1/20 0.38
MAOA P21397 1/20 0.37
MAOB P27338 1/20 0.37
CYP2C9 P11712 1/20 0.37
ABCB1 P08183 2/20 0.36
HTT P42858 1/20 0.36
CYP2C19 P33261 1/20 0.36
SIRT1 Q96EB6 1/20 0.36
GRM2 Q14416 2/20 0.36
GRM3 Q14832 2/20 0.36
POLB P06746 2/20 0.36
MEN1 O00255 1/20 0.36
CYP1A2 P05177 1/20 0.36
KMT2A Q03164 1/20 0.36
GRM8 O00222 1/20 0.36
GRM5 P41594 1/20 0.36
GRM1 Q13255 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27014130 1.00 SMN1; SMN2 (0.39) SMN1; SMN2HPGDEDNRATSHRMAOA
SCHEMBL24496706 1.00 SMN1; SMN2 (0.39) SMN1; SMN2HPGDEDNRATSHRMAOA
SCHEMBL6327386 1.00 SMN1; SMN2 (0.39) SMN1; SMN2HPGDEDNRATSHRMAOA
SCHEMBL29499490 0.86 ATM (0.47) MAOAMAOBCYP2C9SIRT1MEN1
SCHEMBL29587368 0.82 HDAC4 (0.49) HPGDHTTCYP2C19POLB
SCHEMBL24496708 0.82 HDAC4 (0.49) HPGDHTTCYP2C19POLB
SCHEMBL3530476 0.81 SIRT1 (0.41) SMN1; SMN2HPGDTSHRCYP2C9ABCB1
SCHEMBL29586848 0.81 KMT2A (0.41) SMN1; SMN2HPGDTSHRHTTMEN1
SCHEMBL24496707 0.81 KMT2A (0.41) SMN1; SMN2HPGDTSHRHTTMEN1
SCHEMBL29586933 0.81 KMT2A (0.41) SMN1; SMN2HPGDTSHRHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018133-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2024-01-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018133-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 SMN1; SMN2 2611/4885HPGD 861/4885EDNRA 3001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.